BENEFIT IN CENTRAL HAEMODYNAMIC PARAMETERS BY ASSOCIATION ANGIOTENSIN II RECEPTOR BLOCKERS AND CANRENONE THERAPY IN HYPERTENSIVE PATIENTS WITH NORMAL KIDNEY FUNCTION

被引：0
|
作者：
Paterno, C. [1 ]
Mastrorocco, N. [2 ]
Goffredo, I. [2 ]
机构：
[1] Cardiovasc Res Ctr, Foggia, Italy
[2] Pugliese Inst Social & Econ Res, Bari, Italy
来源：
JOURNAL OF HYPERTENSION | 2016年 / 34卷
关键词：
D O I：
10.1097/01.hjh.0000491883.86770.fb
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.13.11
引用
收藏
页码：E194 / E194
页数：1
相关论文
共 50 条
  • [31] Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients
    Guasti, Luigina
    Gaudio, Giovanni
    Lupi, Alessandro
    D'Avino, Marinella
    Sala, Carla
    Mugellini, Amedeo
    Vulpis, Vito
    Felis, Salvatore
    Sarzani, Riccardo
    Vanasia, Massimo
    Maffioli, Pamela
    Derosa, Giuseppe
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2293 - 2300
  • [32] Myocardial Fibrosis and Diastolic Dysfunction Following Calcium-Channel Blockers or Angiotensin II Receptor Blockers in Hypertensive Patients
    Yoshida, Chikako
    Tsujino, Takeshi
    Goda, Akiko
    Matsumoto, Mika
    Naito, Yoshiro
    Nakao, Shinji
    Ezumi, Akira
    Lee-Kawabata, Masaaki
    Masuyama, Tohru
    CIRCULATION, 2008, 118 (18) : S957 - S957
  • [33] The Association of Acute Kidney Injury With Angiotensin Converting Enzyme Inhibitor and Angiotensin Ii Receptor Blockers Use in Patients With Sars-cov-2
    Douen, Aaron
    Sukhoo-Pertab, Marc
    Tan, Samuel
    Panetti, Ryan
    Siu, Wenchy
    Sadeghi, Maryam
    Kaldas, Fady
    Bowser, Carly
    Ramdass, Prakash
    Romney, Wesley
    Juang, George
    Toreli, Aleksandre
    CIRCULATION, 2022, 146
  • [34] INCIDENCE AND PATTERN OF LIVER INJURY DURING ANTI-HYPERTENSIVE THERAPY WITH ANGIOTENSIN-II RECEPTOR BLOCKERS IN KOREAN PATIENTS
    Choi, Won Joon
    Jeong, Sook-Hyang
    Kim, Jin-Wook
    Jang, Eun Sun
    Choi, Gwang Hyeon
    Park, Jaewon
    Jang, Sangmi
    Jung, Woo Jin
    HEPATOLOGY, 2020, 72 : 719A - 719A
  • [35] Survival Benefit of Orally Administered Telmisartan in Hypertensive Rats is NOT a Class Effect Angiotensin II type 1 Receptor Blockers
    Kishi, Takuya
    Hirooka, Yoshitaka
    Sunagawa, Kenji
    CIRCULATION, 2012, 126 (21)
  • [36] Letter regarding the article, "A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients"
    Zhao, Ling-Yue
    Luo, Yi-Jun
    Zhu, Jing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 385 - 386
  • [37] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease
    Kolesnyk, I.
    Struijk, D. G.
    Dekker, F. W.
    Krediet, R. T.
    NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (01): : 15 - 23
  • [38] Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus
    Ozaki, Nobuaki
    Nomura, Yoshio
    Sobajima, Hiroshi
    Kondo, Kunikazu
    Oiso, Yutaka
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2010, 21 (03) : 236 - 239
  • [39] Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Kidney Function in Patients with Sickle Cell Disease
    Choi, Jun
    Singh, Naina
    Han, Jin
    Gowhari, Michel
    Hassan, Johara
    Jain, Shivi
    Molokie, Robert E.
    Gordeuk, Victor R.
    Saraf, Santosh L.
    BLOOD, 2016, 128 (22)
  • [40] Pharmacokinetics and haemodynamic effects of the angiotensin converting enzyme inhibitor cilazapril in hypertensive patients with normal and impaired renal function
    Kloke, HJ
    Ambros, RJ
    VanHamersvelt, HW
    Wetzels, JFM
    Koene, RAP
    Huysmans, FTM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (05) : 615 - 620
12345